Dr. Basturk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Avenue
New York, NY 10065
Education & Training
Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 2010 - 2011
NYU Grossman School of MedicineResidency, Pathology-Anatomic and Clinical, 2006 - 2010
Ege Univ- Fac MedClass of 1999
Certifications & Licensure
NY State Medical License 2010 - 2026
NJ State Medical License 2021 - 2025
American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- Comparison of Ampullary and Pancreatic Adenocarcinomas: Smaller Invasion, Common Adenomatous Components, Resectability, and Histology are Factors for Improved Survival...Bahar Memis, Burcu Saka, Burcin Pehlivanoglu, Grace Kim, Serdar Balci
Annals of Surgical Oncology. 2025-03-01 - ASO Visual Abstract: Comparison of Ampullary and Pancreatic Adenocarcinomas-Smaller Invasion, Common Adenomatous Components, Resectability, and Histology are Factors f...Bahar Memis, Burcu Saka, Burcin Pehlivanoglu, Grace Kim, Serdar Balci
Annals of Surgical Oncology. 2025-03-01 - Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival.Anna M Varghese, Maria A Perry, Joanne F Chou, Subhiksha Nandakumar, Daniel Muldoon
Nature Medicine. 2025-01-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
